Listen

Information updates

ASCIA Progress Report - National Allergy Council Schools and Childcare project - February 2023

ASCIA’s involvement in the National Allergy Council Schools and Childcare project includes education and training of staff in schools and Children's Education/Care (CEC) Services. 

The following information summarises the progress of ASCIA’s involvement in the project as at 9 February 2023, in regards to: 

  • Increasing the uptake of ASCIA anaphylaxis e-training for schools and CEC
  • Scoping education undergraduate training

Increasing the uptake of ASCIA anaphylaxis e-training for schools and CEC

  • To obtain feedback in 2023 about ASCIA anaphylaxis e-training courses for schools, CEC and community a short survey is now included at the end of the courses, which will only take users a few minutes to complete before they obtain their certificate of course completion. All information collected will be anonymous and courses can be accessed here.
  • ASCIA e-training surveys used to be optional, whereas now they need to be completed before users obtain their certificate of course completion.
  • Once data is collated and reviewed, ASCIA anaphylaxis e-training courses will be updated as required based on feedback.
  • ASCIA will continue to maintain and provide user support for ASCIA anaphylaxis e-training courses.

Scoping education undergraduate training

Whilst we are aware that some undergraduate school teaching courses include ASCIA e-training, we do not know the extent of this, and if is mandatory or optional.

To scope the benefits, enablers and barriers for incorporating allergy training into undergraduate school teacher training ASCIA will:

  • Conduct a gap analysis to determine current allergy education being provided in universities.
  • Engage with relevant stakeholders to determine the benefits, enablers and barriers for incorporating allergy training into undergraduate training.
  • Work with NAC and other relevant organisations to develop minimum competencies.
  • Provide a report with the findings of the above activities.

This news item was issued on 9 February 2023 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.